Stock listing

OTC:POLBF Poolbeg Pharma PLC Stock

US listing (OTC) of Poolbeg Pharma PLC · home listing LSE:POLB

Follow Poolbeg Pharma PLC into a list and get an email when it puts out news.

Home listing price · LSE:POLB

6.15p GBX (pence) -0.25 (-3.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:POLB

Past year +61.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
6.10p – 6.30p GBX (pence)Nov 20, 2026
Volume
998,803 sharesNov 20, 2026
Market cap
£46.95M GBPAt the close on Nov 20, 2026 · price × 763.4M shares outstanding
52-week range
3.30p – 9.30p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£132,845 GBPMedian day 1.03M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Poolbeg Pharma PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:POLB · Home6.15p GBX (pence)-0.25 (-3.9%)998,8036.20p6.30p6.10p6.40pClose on Nov 20, 2026
Frankfurt:7JN€0.063 EUR+0.002 (+3.3%)—€0.063€0.063€0.063€0.061Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:POLB · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
6.15p-0.25-3.9%6.20p6.30p6.10p998,803
6.40p-0.05-0.8%6.45p6.50p6.275p731,243
6.45p+0.35+5.7%6.10p6.50p5.90p1,646,207
6.10p+0.25+4.3%5.85p6.30p5.80p1,033,488
5.85p0.000.0%5.85p6.00p5.70p98,345
5.85p0.000.0%5.85p6.00p5.75p403,210
5.85p+0.05+0.9%5.80p6.00p5.73p221,855
5.80p-0.20-3.3%6.00p6.00p5.70p732,626
6.00p-0.05-0.8%6.05p6.05p5.90p325,787
6.05p+0.05+0.8%6.10p6.20p6.00p346,435
6.00p-0.40-6.3%6.30p6.30p6.00p1,102,742
6.40p0.000.0%6.40p6.45p6.30p185,026
6.40p0.000.0%6.40p6.50p6.30p215,082
6.40p-0.10-1.5%6.50p6.70p6.30p415,295
6.50p0.000.0%6.50p6.60p6.30p403,346
6.50p-0.15-2.3%6.65p6.695p6.332p304,561
6.65p0.000.0%6.65p6.697p6.50p460,013
6.65p-0.10-1.5%6.75p6.897p6.60p778,385
6.75p+0.09+1.4%6.45p6.897p6.335p1,528,062
6.66p+0.16+2.5%6.50p6.66p6.315p287,905
6.50p+0.25+4.0%6.25p6.70p6.10p1,865,446
6.25p0.000.0%6.25p6.40p5.894p2,248,702
6.25p0.000.0%6.25p6.40p6.10p584,172
6.25p-0.05-0.8%6.30p6.50p6.10p247,094
6.30p-0.30-4.5%6.40p6.50p6.10p929,307
6.60p+0.20+3.1%6.35p6.60p6.20p643,308
6.40p-0.10-1.5%6.50p6.60p6.30p1,580,972
6.50p-0.40-5.8%6.90p6.90p6.30p2,972,319
6.90p0.000.0%6.90p7.00p6.80p412,852
6.90p0.000.0%6.90p7.00p6.833p583,157
6.90p0.000.0%6.90p7.00p6.80p489,113
6.90p-0.30-4.2%7.15p7.21p6.80p3,245,625
7.20p+0.20+2.9%7.10p7.30p6.90p831,462
7.00p-0.18-2.5%7.10p7.30p6.90p594,920
7.18p-0.17-2.3%7.35p7.50p6.90p1,127,024
7.35p-0.05-0.7%7.35p7.50p7.20p1,029,441
7.40p0.000.0%7.35p7.50p7.20p554,887
7.40p+0.05+0.7%7.35p7.50p7.20p545,125
7.35p+0.25+3.5%7.10p7.60p7.052p6,680,306
7.10p-0.80-10.1%7.85p8.00p6.56p15,336,310
7.90p-1.15-12.7%9.15p9.30p7.50p10,213,737
9.05p+0.05+0.6%9.00p9.30p8.80p1,511,750
9.00p0.000.0%9.00p9.20p8.802p647,637
9.00p+0.15+1.7%8.85p9.20p8.70p2,766,692
8.85p-0.20-2.2%9.05p9.30p8.70p528,905
9.05p+0.10+1.1%8.95p9.30p8.80p1,241,303
8.95p+0.25+2.9%8.70p9.14p8.60p2,953,490
8.70p+0.30+3.6%8.40p8.80p8.30p720,027
8.40p+0.10+1.2%8.35p8.50p8.30p849,412
8.30p-0.10-1.2%8.40p8.55p8.30p2,518,226
8.40p+0.05+0.6%8.35p8.50p8.30p1,298,629
8.35p-0.05-0.6%8.40p8.50p8.30p331,576
8.40p+0.10+1.2%8.35p8.50p8.30p1,684,536
8.30p+0.05+0.6%8.25p8.44p8.20p1,407,519
8.25p-0.33-3.8%8.40p8.50p8.20p1,473,549
8.58p+0.34+4.1%8.25p8.58p8.20p4,492,676
8.24p-0.11-1.3%8.35p8.50p8.20p1,126,084
8.35p-0.25-2.9%8.45p8.80p8.30p2,166,547
8.60p+0.20+2.4%8.45p8.60p8.30p2,290,227
8.40p-0.20-2.3%8.65p9.00p8.40p3,210,258
8.60p0.000.0%8.60p8.80p8.40p1,816,142
8.60p+0.10+1.2%8.50p9.00p8.40p4,910,295
8.50p-0.30-3.4%8.80p9.00p8.40p3,090,204
8.80p-0.20-2.2%8.95p9.20p8.70p1,909,752
9.00p+0.35+4.0%8.65p9.20p8.50p2,656,061
Ticker
OTC:POLBF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Poolbeg Pharma (LSE:POLB) — Company Presentation

    Thu, Sep 24, 2026 · 9:00 AM ET

    Watch Transcript
  • Poolbeg Pharma (LSE:POLB) Q4 2025 Earnings Call

    Tue, Apr 28, 2026 · 12:00 PM ET

    Watch Transcript
  • Poolbeg Pharma (LSE:POLB) — POLB 001 Phase 2a Trial Update

    Mon, Sep 29, 2025 · 12:00 PM ET

    Watch Transcript

Latest news

POLB001 CRS Patent Granted in South Korea

Oct 6, 2026

Closed 7.20p (+2.9%) on Oct 6, 2026

POLB 001 TOPICAL trial recruitment update

Sep 28, 2026

Closed 7.35p (+3.5%) on Sep 28, 2026

Notification of major holdings

Jul 23, 2026

Closed 6.15p (+0.8%) on Jul 23, 2026

Placing to raise £3.5 million

Jul 14, 2026

Closed 6.05p (-13.6%) on Jul 14, 2026

POLB 001 patent granted in South Africa

Jun 30, 2026

Closed 6.85p (+1.5%) on Jun 30, 2026

All Poolbeg Pharma PLC news

Financings

  • Private placement of new ordinary shares

    Sep 29, 2026 · US$4.63M

    Closed: £3.5M raised · GBX 6 a share · OAK Securities

    Dealers: OAK Securities (lead)

    Buyers: Cathal Friel (£250,000 subscription)

    Insiders: Executive Chair Cathal Friel subscribed a further £250,000

    Use of proceeds: Fund the POLB 001 TOPICAL trial and the oral GLP-1 proof-of-concept trial to completion; strengthen partnering position

    Announced Jul 14, 2026 · Closed Sep 29, 2026

  • Private placement of new ordinary shares

    Jun 23, 2025 · US$6.56M

    Made bigger: £4.87M · GBX 2.5 a share · Shore Capital +1

    Dealers: Shore Capital (lead), Shore Capital Stockbrokers Limited (lead)

    Buyers: Cathal Friel (4,000,000 new Ordinary Shares, investment of £100,000)

    Insiders: Executive Chair Cathal Friel subscribed for 4,000,000 new Ordinary Shares, an investment of £100,000

    Use of proceeds: Phase 2a trial of POLB 001 for cancer immunotherapy-induced CRS, oral GLP-1 proof-of-concept trial, cash runway into 2027

    Announced May 20, 2025 · Made bigger May 20, 2025 · Update May 27, 2025 · Update Jun 23, 2025

  • BookBuild Offer Shares (new ordinary shares)

    May 22, 2025 · US$201,316

    Made bigger: £150,000 · GBX 2.5 a share · Shore Capital +1

    Dealers: Shore Capital (lead), Shore Capital Stockbrokers Limited

    Use of proceeds: Fund POLB 001 Phase 2a trial and oral GLP-1 proof of concept trial, providing runway into 2027

    Announced May 20, 2025 · Made bigger May 22, 2025

Read by 6ix AI from the company's releases

Decks

Poolbeg Pharma PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 144 in all · newest Oct 6, 2026 · oldest 2021
Calls
12 calls with a replay · 12 with a transcript · latest Sep 24, 2026
Decks
16 decks · latest Oct 28, 2026

Where Poolbeg Pharma PLC is listed

ListingExchangeCountryCurrency
LSE:POLB · Home listingLSEUnited KingdomGBX
OTC:POLBF · This pageOTCUnited StatesUSD
Frankfurt:7JNFrankfurtGermanyEUR
Stuttgart:7JNStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Poolbeg Pharma PLC.